Generische Daklinza is een antiviraal geneesmiddel dat voorkomt dat het hepatitis C-virus (HVC) zich vermenigvuldigt in uw lichaam. Daclatasvir wordt gebruikt om genotype 3 chronische hepatitis C te behandelen bij volwassenen zonder cirrose. Het geneesmiddel wordt toegediend in combinatie met een ander medicijn genaamd sofosbuvir.

Natdac® is an inhibitor of the viral (hepatitis C virus) protein NS5A, which is used in the replication of hepatitis C virus within the liver cells (hepatocytes) and, thus, prevents the virus from entering infected hepatocytes into the blood. Thanks to this action, it is possible to prevent the spread of the virus in the body. Natdac® (daсlatasvir) is a highly specific direct action agent against hepatitis C virus (HCV) and has no pronounced activity against other RNA and DNA containing viruses, including human immunodeficiency virus (HIV). Natdac®, as an inhibitor of the nonstructural protein 5A (NS5A), a multifunctional protein required for HCV replication, suppresses two stages of the life cycle of the virus-viral RNA replication and virion assembly.